Daily Archives: February 6, 2014

Rebiotix Completes Enrollment for Trial Using Microbiota Restoration Therapy for Treatment of Recurrent Clostridium difficile Infection

This is the first multi-center study of a next-generation fecal transplant. The PUNCH™ CD study, sponsored by Rebiotix Inc., has completed enrollment. This study represents Rebiotix’s progress toward developing and commercializing a new non-antibiotic, therapy to treat patients with recurrent episodes of debilitating and potentially life-threatening Clostridium difficile infection (CDI). […]